Ownership history in CITIGROUP INC · 159 quarters on record
This page tracks every 13F SEC filing in which CITIGROUP INC reported a position in SPDR SERIES TRUST S&P BIOTEC (XBI). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 351,200 | +111,200 | +46.3% | 0.02% | $42.8M | $121.93 |
| 2025 Q4 | REDUCED | 240,000 | -12,287,210 | -98.1% | 0.01% | $29.3M | $121.93 |
| 2025 Q4 | ADDED | 12,527,210 | +12,140,510 | +3139.5% | 0.67% | $1.53B | $121.93 |
| 2025 Q3 | ADDED | 386,700 | +136,100 | +54.3% | 0.02% | $38.7M | $99.87 |
| 2025 Q3 | REDUCED | 250,600 | -10,640,291 | -97.7% | 0.01% | $25.1M | $99.87 |
| 2025 Q3 | ADDED | 10,890,891 | +10,260,891 | +1628.7% | 0.49% | $1.09B | $99.87 |
| 2025 Q2 | REDUCED | 630,000 | -12,123,740 | -95.1% | 0.03% | $52.2M | $82.63 |
| 2025 Q2 | ADDED | 12,753,740 | +12,583,740 | +7402.2% | 0.52% | $1.06B | $82.63 |
| 2025 Q2 | REDUCED | 170,000 | -10,307,966 | -98.4% | 0.01% | $14.1M | $82.63 |
| 2025 Q1 | ADDED | 10,477,966 | +10,112,966 | +2770.7% | 0.43% | $849.8M | $80.80 |
As of 2025 Q4 — sorted by position size